|
|
||||||||
J Thorac Cardiovasc Surg 2003;126:1489-1497
© 2003 The American Association for Thoracic Surgery
Cardiopulmonary support and physiology |
a Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC, USA
Received for publication February 5, 2003; revisions received March 24, 2003; accepted for publication May 19, 2003. * Address for reprints: Francis G. Spinale, MD, PhD, Cardiothoracic Research, Strom Thurmond Research Building, 770 MUSC Complex, Suite 625, Medical University of South Carolina, Charleston, SC 29425., USA
BACKGROUND: A mechanism for myocardial dysfunction after ischemia and reperfusion is Na+/H+ exchanger activation. Although past in vivo models of limited ischemia and reperfusion intervals demonstrate that Na+/H+ exchanger inhibition confers myocardial protection when administered at the onset of ischemia, the effect of Na+/H+ exchanger inhibition on myocardial function after prolonged ischemia and reperfusion remains unknown. This investigation tested the hypothesis that Na+/H+ exchanger inhibition instituted at reperfusion and after prolonged coronary occlusion in pigs would influence myocardial contractility independent of myocardial viability.
METHODS: A coronary snare and sonomicrometry crystals were placed in pigs (n = 21, 32 kg). Coronary occlusion was instituted for 120 minutes followed by reperfusion for 180 minutes. At 105 minutes of ischemia, pigs were randomized to ischemia and reperfusion only (saline solution, n = 11) or Na+/H+ exchanger inhibition (HOE-642, 3 mg/kg intravenously, n = 10). Myocardial injury was determined by tissue staining and measurement of plasma myocytespecific enzymes. Myocardial contractility was determined by calculation of the regional end-systolic pressure-dimension relation (millimeters of mercury per centimeter) and by assessment of interregional shortening.
RESULTS: Infarct size was not different between groups (39% ± 6%, P = .26). Moreover, at 180 minutes of reperfusion, plasma troponin-I and creatine kinase MB values had increased to identical levels in the ischemia and reperfusiononly and Na+/H+ exchanger inhibition groups (300 ± 35 and 50 ± 6 ng/mL, respectively). At 90 minutes of ischemia, regional end-systolic pressure-dimension relation decreased from baseline (5.7 ± 0.5 versus 2.7 ± 0.3, P < .05) in the area at risk. By 30 minutes of reperfusion, regional end-systolic pressure-dimension relation decreased further in the ischemia and reperfusiononly group (1.6 ± 0.2, P < .05), but improved with Na+/H+ exchanger inhibition (4.4 ± 0.7, P < .05).
CONCLUSIONS: Na+/H+ exchanger inhibition instituted at reperfusion improved contractility independent of myocardial viability as assessed by absolute infarct size and myocyte-specific enzyme release. Thus, modulation of Na+/H+ exchanger activity in the setting of prolonged ischemia and reperfusion may hold therapeutic potential.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |